Randomised crossover trial examines polyphenol effects on TMAO levels in postmenopausal women, suggesting new health interventions.
Menopause increases cardiometabolic risk, partly by reducing the protective effects of estrogens and inducing gut microbiota dysbiosis, which can promote the production of atherogenic metabolites such as trimethylamine N-oxide (TMAO)....
No takes yet. Share an insight, caveat, or question.
Jarrín-Orozco et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: